To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges the Departments to adopt the Committee’s recommended “Eat Healthy Your Way” dietary pattern in the 2025-2030 DGA, which builds on previous iterations of the DGA by encouraging people to consume more plant-based proteins while allowing for greater flexibility to meet the needs of American families.
GFI asks the DGAC to consider the unique health, environmental, and societal benefits of alternative proteins that make it inappropriate to classify them with other UPFs.